NEA Management Company, LLC Buys Sprout Social Inc, Trillium Therapeutics Inc, Genocea Biosciences Inc, Sells Dermira Inc, AVEO Pharmaceuticals Inc, Marker Therapeutics Inc

• New Purchases: SPT, GNCA, MRKR, VPA1, 4NX1, ELGX,
• Added Positions: TRIL, ADAP, CTIC, CSBR,
• Reduced Positions: SENS,
• Sold Out: DERM, AVEO, GX1N,

For the details of NEA Management Company, LLC's stock buys and sells, go to https://www.gurufocus.com/guru/nea+management+company%2C+llc/current-portfolio/portfolio

1. Ra Pharmaceuticals Inc (RARX) - 6,138,797 shares, 20.83% of the total portfolio.
2. Sprout Social Inc (SPT) - 9,046,080 shares, 10.21% of the total portfolio. New Position
3. Allakos Inc (ALLK) - 2,268,188 shares, 7.13% of the total portfolio.
4. Cloudflare Inc (NET) - 4,059,376 shares, 6.74% of the total portfolio.
5. Ardelyx Inc (ARDX) - 16,135,047 shares, 6.48% of the total portfolio.

NEA Management Company, LLC initiated holding in Sprout Social Inc. The purchase prices were between $13 and $21.72, with an estimated average price of $18.25. The stock is now traded at around $18.01. The impact to a portfolio due to this purchase was 10.21%. The holding were 9,046,080 shares as of .

NEA Management Company, LLC initiated holding in Genocea Biosciences Inc. The purchase prices were between $1.26 and $2.73, with an estimated average price of $2.03. The stock is now traded at around $2.24. The impact to a portfolio due to this purchase was 0.88%. The holding were 7,225,676 shares as of .

NEA Management Company, LLC initiated holding in Marker Therapeutics Inc. The purchase prices were between $1.59 and $3.35, with an estimated average price of $2.57. The stock is now traded at around $2.32. The impact to a portfolio due to this purchase was 0.67%. The holding were 5,000,000 shares as of .

NEA Management Company, LLC initiated holding in AVEO Pharmaceuticals Inc. The purchase prices were between $2.36 and $6.05, with an estimated average price of $4.51. The stock is now traded at around $7.45. The impact to a portfolio due to this purchase was 0.65%. The holding were 2,524,387 shares as of .

NEA Management Company, LLC initiated holding in Lumos Pharma Inc. The purchase prices were between $6.65 and $21.96, with an estimated average price of $12.74. The stock is now traded at around $8.50. The impact to a portfolio due to this purchase was 0.32%. The holding were 526,663 shares as of .

NEA Management Company, LLC initiated holding in Endologix Inc. The purchase prices were between $0.66 and $2.04, with an estimated average price of $1.24. The stock is now traded at around $0.89. The impact to a portfolio due to this purchase was 0.01%. The holding were 249,022 shares as of .

NEA Management Company, LLC added to a holding in Trillium Therapeutics Inc by 173.16%. The purchase prices were between $1.03 and $7.22, with an estimated average price of $3.72. The stock is now traded at around $5.35. The impact to a portfolio due to this purchase was 1.04%. The holding were 5,736,363 shares as of .

NEA Management Company, LLC added to a holding in CTI BioPharma Corp by 90.41%. The purchase prices were between $0.69 and $1.58, with an estimated average price of $1.16. The stock is now traded at around $1.01. The impact to a portfolio due to this purchase was 0.22%. The holding were 7,140,450 shares as of .

NEA Management Company, LLC sold out a holding in Dermira Inc. The sale prices were between $14.65 and $19.19, with an estimated average price of $18.32.

NEA Management Company, LLC sold out a holding in AVEO Pharmaceuticals Inc. The sale prices were between $2.6 and $6.86, with an estimated average price of $5.01.

NEA Management Company, LLC sold out a holding in Marker Therapeutics Inc. The sale prices were between $1.48 and $2.93, with an estimated average price of $2.32.